NDC 51662-1315

LEVOPHED(R) NOREPINEPHRINE BITARTRATE

Levophed(r) Norepinephrine Bitartrate

LEVOPHED(R) NOREPINEPHRINE BITARTRATE is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Norepinephrine Bitartrate.

Product ID51662-1315_788b6c64-1b6e-0058-e053-2a91aa0aa99c
NDC51662-1315
Product TypeHuman Prescription Drug
Proprietary NameLEVOPHED(R) NOREPINEPHRINE BITARTRATE
Generic NameLevophed(r) Norepinephrine Bitartrate
Dosage FormInjection, Solution, Concentrate
Route of AdministrationINTRAVENOUS
Marketing Start Date2018-10-18
Marketing CategoryNDA / NDA
Application NumberNDA007513
Labeler NameHF Acquisition Co LLC, DBA HealthFirst
Substance NameNOREPINEPHRINE BITARTRATE
Active Ingredient Strength1 mg/mL
Pharm ClassesCatecholamine [EPC],Catecholamines [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 51662-1315-1

4 mL in 1 VIAL, SINGLE-DOSE (51662-1315-1)
Marketing Start Date2018-10-18
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51662-1315-1 [51662131501]

LEVOPHED(R) NOREPINEPHRINE BITARTRATE INJECTION, SOLUTION, CONCENTRATE
Marketing CategoryNDA
Application NumberNDA007513
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-10-18
Inactivation Date2020-01-31
Reactivation Date2020-02-07

Drug Details

Active Ingredients

IngredientStrength
NOREPINEPHRINE BITARTRATE1 mg/mL

OpenFDA Data

SPL SET ID:788b6c64-1b6d-0058-e053-2a91aa0aa99c
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 242969
  • Pharmacological Class

    • Catecholamine [EPC]
    • Catecholamines [CS]

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.